Its deputy minister, Ahmad Amzad Hashim, said of the total allocation, RM54 million was allocated to the Malaysia Genome Institute while RM2.5 million was for the research team to develop vaccines using the Messenger Ribonucleic Acid (mRNA) technology.

“Another RM2.5 million is allocated for vaccine development from inactivated toxins produced by germs at Universiti Putra Malaysia,” he said after officiating the community vaccine mobilisation programme for the Tawang state constituency at Pantai Senok here today.

He said through R&D, the ministry expected a vaccine to be produced within two to five years, adding that it practised science diplomacy with foreign countries and universities for this purpose.

“For example, in the study of the mRNA vaccine, we’re collaborating with the Chulalongkorn University in Thailand which pioneered the development of the vaccine.

“This process involves international relations, where the ministry and relevant parties play an important role for the successful development of the vaccine,” he said.

Ahmad also hoped that Malaysia would become the producer and importer of vaccines, especially for the Muslim market.

“We hope that through the involvement of the National Pharmaceutical Regulatory Agency (NPRA) and Department of Islamic Development Malaysia (Jakim) in the early stage, we will gain an advantage because the Muslim community will be more confident if the vaccine is produced by a Muslim country,” he said.

CLICK HERE FOR THE LATEST DATA ON THE COVID-19 SITUATION IN MALAYSIA